Track topics on Twitter Track topics that are important to you
Technavio’s latest market research report on the global clostridium diagnostics marketprovides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technaviodefines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170801005883/en/
Technavio has published a new report on the global clostridium diagnostics market from 2017-2021. (Graphic: Business Wire)
The global Clostridium diagnostics market is expected to grow at a CAGR of close to 15% during the forecast period. The emerging countries in Asia-Pacific such as India and China are expected to witness lucrative growth during the forecast period owing to the increasing healthcare infrastructure, rising healthcare expenditure, and growing prevalence of infectious diseases.
According to Neha Noopur, a lead analyst at Technavio for in-vitro diagnostics research, “Clostridium diagnostics market also has a strong presence in North America and Europe, owing to the presence of technologically advanced systems, high healthcare expenditure, increased government funding, increasing expenditure on R&D programs, and high patient awareness levels.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The top three emerging market trends driving the global clostridium diagnostics market according to Technavio research analysts are:
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
The use of automation and robots in clinical laboratories has become more prevalent today. The pressure on the laboratories to produce faster results and reduce errors to improve patient care has increased. The current technologies in laboratory automation can automate specimen transportation, sorting, accessioning, and inspection. Over the decade, the pressure to reduce healthcare costs has increased, and hence, laboratories are relying on automation to maintain profitability. Currently, over 30% of laboratories in Japan, Europe, and North America has implemented a significant degree of laboratory automation.
Laboratory automation is now becoming a well-accepted technology, which offers high-quality, efficient, and patient-centric operations with low operating costs. Automation can also be the foundation on which the Six Sigma program can be built and maintained. Technological advancements have led to several laboratory operations to be partially or fully automated.
Increasing focus on reducing nosocomial infections
It is estimated that across the globe 5%-10% of hospitalized patients experience hospital-acquired infections (HAIs) every year. Though preventable, health systems, providers, and patients spend large amounts each year to treat these infections. In the US, they affect 1 in 20 hospitalized patients.
The responsible health authorities in the US have developed a national program to support hospitals in reducing the risk of nosocomial infections. The government in the US has increased its funding for these programs to eliminate HAIs. In March 2011, ASTHO and CDC jointly released the toolkit, Eliminating HAI. Different programs are being run by the government to increase awareness among people.
Growing popularity of portable POCT products
Fixed point-of-care testing (POCT) products are expensive and difficult to control at times because of slow data processing. On the other hand, portable POCT products are comparatively inexpensive, more hygienic and efficient, and backed by warranties. Advances in technology have aided manufacturers to develop innovative portable POCT products with licenses for single-owner use.
“The POCT products are expected to replace the traditional coagulation devices due to their low cost and effectiveness. POCT is expected to play a vital role in developing nations in the future. The segment is likely to grow with many devices being developed, and released into the market during the forecast period,” says Neha.
Browse Related Reports:
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...